Life Science Analysis: What does Roche’s takeover of Flatiron Health mean?

With Roche being particularly active on the real-world-data front with its recent acquisition of the US cancer data analytics firm Flatiron Health Inc, Healthcare Analyst Tara Raveendran discusses the broader implications of this transaction.

Tara Raveedran’s article was published in the April 2018 edition of MedNous, a publication of Evernow Publishing Ltd, and is available to download here.

 

 

Tara Raveendran

Healthcare Analyst, Research

+44 (0)20 7647 8142

Our website uses necessary cookies in order for it to run. We would also like to use optional analytics cookies to improve the site, by collecting and reporting information on how you use it. These cookies do not directly identify the user and won’t set optional cookies unless they are accepted. For more information on how our site cookies work, please see our Privacy Policy.